Search results
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by OLD National Bancorp IN
ETF DAILY NEWS· 19 hours agoOLD National Bancorp IN lowered its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 3.4% during the fourth quarter, according ...
Lindbrook Capital LLC Raises Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)
ETF DAILY NEWS· 22 hours agoLindbrook Capital LLC boosted its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 37.0% during the 4th quarter, Holdings Channel.com ...
UBS Group Trims Gilead Sciences (NASDAQ:GILD) Target Price to $75.00
ETF DAILY NEWS· 4 days agoGilead Sciences (NASDAQ:GILD – Free Report) had its price objective reduced by UBS Group from $81.00 to $75.00 in a research note issued to investors on ...
Analyst Report: Gilead Sciences, Inc.
Argus Research via Yahoo Finance· 17 hours agoGilead Sciences is a biopharmaceutical company that researches, develops, and sells therapies for treating HIV, hepatitis B, hepatitis C, and certain cancers ...
Handelsbanken Fonder AB Buys 10,401 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
ETF DAILY NEWS· 2 days agoHandelsbanken Fonder AB raised its stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 1.9% during the fourth quarter, according to its most recent ...
Gilead Sciences’ (GILD) Outperform Rating Reiterated at Oppenheimer
ETF DAILY NEWS· 2 days agoThe brokerage currently has a $105.00 price objective on the biopharmaceutical company’s stock. Truist Financial downgraded shares of Gilead Sciences from ...
Insider Buying: GILEAD SCIENCES, INC., Gilead Sciences, Inc. [GILD] 10% Owner invested 485,250...
Knox Daily· 5 days agoInvestors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Gilead Sciences, Inc. shares valued at ...
Truist’s latest rating for GILD stock – Knox Daily
Knox Daily· 22 hours agoGilead Sciences, Inc.’s recent filing unveils that its 10% Owner GILEAD SCIENCES, INC. acquired Company’s shares for ...
Gilead Sciences (GILD) to Release Earnings on Thursday
ETF DAILY NEWS· 6 days agoGilead Sciences (NASDAQ:GILD – Get Free Report) will be issuing its quarterly earnings data after the market closes on Thursday, April 25th. Gilead ...
Gilead Sciences (GILD) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Zacks· 6 days agoFree Report) closed at $66.16, marking a -1.15% move from the previous day. The stock fell short of the S&P 500, which registered a loss of 0.22% for the day. The HIV and hepatitis C drugmaker's ...
